Longhao Sun
Overview
Explore the profile of Longhao Sun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun L, Sun S, Liu T, Lei X, Liu R, Zhang J, et al.
Microorganisms
. 2025 Jan;
13(1).
PMID: 39858975
Halotolerant plant growth-promoting bacteria (HT-PGPB) have attracted considerable attention for their significant potential in mitigating salt stress in crops. However, the current exploration and development of HT-PGPB remain insufficient to...
2.
Sun R, Yu J, Zou Z, Yang S, Tuo Y, Tan L, et al.
Int Immunopharmacol
. 2025 Jan;
147():113943.
PMID: 39752758
Background: FcγRI, a pivotal cell surface receptor, is implicated in diverse immune responses and is ubiquitously expressed on numerous immune cells. However, its role in intracellular bacterial infections remains understudied....
3.
Fan Y, Ding L, Li W, Sun L, Li X, Chang L, et al.
Diabetes Obes Metab
. 2024 Nov;
27(2):595-605.
PMID: 39511849
Objective: The associations of lean mass distribution with mortality risk are not fully elucidated. We aimed to evaluate the effects of a new lean mass distribution indicator-android/gynoid lean mass ratio...
4.
Xiao J, Zhang X, Chang L, Yu H, Sun L, Zhu C, et al.
Endocrine
. 2024 May;
86(2):546-555.
PMID: 38814373
Objectives: This study was designed to evaluate the association of four surrogate indexes of IR with NASH in patients with obesity. Methods: A total of 270 patients who underwent bariatric...
5.
Yang T, Han Y, Chen J, Liang X, Sun L
Biomedicines
. 2023 Nov;
11(11).
PMID: 38001876
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer with a poor prognosis, and effective treatments for PDAC are lacking. In this study, we hypothesized that miR-506 promotes antitumor immune...
6.
Xiao J, Zhang X, Zhu C, Gu Y, Sun L, Liang X, et al.
Obes Surg
. 2023 Aug;
33(10):3246-3255.
PMID: 37644345
Purpose: The aim of this study was to explore risk factors of NASH and then develop a non-invasive scoring model in Chinese patients with obesity. A scoring system was then...
7.
Zhu C, Tang S, Xiao J, Zhang Y, Sun L, Zhang J, et al.
Obes Facts
. 2023 Feb;
16(4):344-355.
PMID: 36854279
Introduction: Severe obesity is often present with non-alcoholic fatty liver disease (NAFLD) and obstructive sleep apnea (OSA). Emerging researches suggest OSA plays an important role in NAFLD development and progression...
8.
Yang T, Zhang Y, Chen J, Sun L
Front Med (Lausanne)
. 2023 Feb;
10:1125692.
PMID: 36814780
Autophagy is a conserved process for self-degradation and provides cells with a rescue mechanism to respond to circumstances such as stress and starvation. The role of autophagy in cancer is...
9.
Sun L, Zhang Y, Yang T, Chen J, Zhang X, Liang X
J Pers Med
. 2022 Dec;
12(12).
PMID: 36556226
Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest malignancies. Elevated regulatory T cell (Treg) infiltration has a potent immunosuppressive function in tumor biology, which contributes to low survival in...
10.
Xiao J, Zhu C, Zhang X, Sun L, Gao C, Liang X, et al.
Endocr J
. 2022 Jan;
69(6):659-667.
PMID: 35034938
Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic metabolic disorder. Thyroid function is associated with NAFLD in different populations; however, little attention has been paid in patients with...